(SPAC) Special Purpose Acquisition Investigation: PRDS, GMTX, SNTI, TNGX - Contact Shareholder Rights Law Firm Johnson Fistel

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Wednesday, August 2, 2023

Information

Tags:

SNTI, LLP, Acquisition, Therapy, SAN, Roman Catholic Diocese of La Crosse, Pharmaceutical industry, Medical device, 3D printing, Financial services, Security (finance)

Geotags:

SAN DIEGO, CA, US

⚠ partially generated by AI ↴

Organisation:

JOHNSON FISTEL, JOHNSON FISTEL, LLP

Stock Symbol:

Summary

Key Points:

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):
Gemini Therapeutics f/k/a FS Development Corp., (NASDAQ: GMTX)
Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:
Shareholders who purchased FS Development Corp II and continue to hold their shares are encouraged to submit their information by following the link below:
Gemini Therapeutics f/k/a FS Development Corp. (NASDAQ: GMTX):
Shareholders who purchased FS Development Corp. and continue to hold their shares are encouraged to submit their information by following the link below:
Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):
Shareholders who purchased Dynamics Special Purpose Corp and continue to hold their shares are encouraged to submit their information by following the link below:
Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):
Shareholders who purchased BCTG Acquisition Corp and continue to hold their shares are encouraged to submit their information by following the link below:

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"):

Pardes Biosciences, Inc. f/k/a FS Development Corp. II (NASDAQ: PRDS)

Gemini Therapeutics f/k/a FS Development Corp., (NASDAQ: GMTX)

Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):

Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):

If you are an investor purchasing any of the SPACs below and suffered losses: Click or paste the following web address into your browser to submit your information:

Pardes Biosciences, Inc. f/k/a FS Development Corp. II (NASDAQ: PRDS):

Shareholders who purchased FS Development Corp II and continue to hold their shares are encouraged to submit their information by following the link below:

https://www.johnsonfistel.com/investigations/pardes-biosciences-inc-fs-development

Gemini Therapeutics f/k/a FS Development Corp. (NASDAQ: GMTX):

Shareholders who purchased FS Development Corp. and continue to hold their shares are encouraged to submit their information by following the link below:

https://www.cognitoforms.com/JohnsonFistel/GeminiTherapeuticsFkaFSDevelopmentCorp

Senti Biosciences Inc. f/k/a Dynamics Special Purpose Corp (NASDAQ: SNTI):

Shareholders who purchased Dynamics Special Purpose Corp and continue to hold their shares are encouraged to submit their information by following the link below:

https://www.cognitoforms.com/JohnsonFistel/sentibiosciencesincfkadynamicsspecialpurposecorp2

Tango Therapeutics, Inc. f/k/a BCTG Acquisition Corp (NASDAQ: TNGX):

Shareholders who purchased BCTG Acquisition Corp and continue to hold their shares are encouraged to submit their information by following the link below:

https://www.cognitoforms.com/JohnsonFistel/TangoTherapeuticsIncFkaBCTGAcquisitionCorp3

Or for more information, contact Jim Baker at [email protected] or (619) 814-4471

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
Investor Relations
[email protected]

Frank Johnson, 619-309-4405
[email protected]